Prepare for your visit
Katey Robinfield
Medical · Winston Salem, NC · NPI 1386261451
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$4,997.61
in general payments reported to CMS, 2019-2025 · $851 in 2025
The $851 reported for 2025 was more than what 77% of Medical providers received nationally (typical 2025 total: $213).
Who reported paying
General payments only, top 6 by amount.
- Boehringer Ingelheim Pharmaceuticals, INC. $688.39
- United Therapeutics Corporation $609.09
- Glaxosmithkline, LLC. $537.23
- Regeneron Healthcare Solutions, INC. $526.09
- Astrazeneca Pharmaceuticals LP $500.45
- Mallinckrodt Hospital Products INC. $305.64
Drugs and devices associated with these payments
Dupixent Tyvaso Ofev Acthar Trelegy Ellipta Fasenra Airsupra Nucala Arexvy Ohtuvayre Glassia Breztri
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Katey Robinfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11254252/katey-robinfield